DCM
CLMT icon

Deuterium Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Deuterium Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,703
Closed -$172K – 43
2024
Q2 		$172K Hold
10,703
– – 0.29% 35
2024
Q1 		$159K Buy
+10,703
New +$171K 0.28% 36

Other funds holding CLMT

WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Deuterium Capital Management's CLMT Position: Q3 2024 in Review

Deuterium Capital Management sold out of Calumet Specialty Products (CLMT) in Q3 2024, closing a stake of 10,703 shares — an estimated $172K sold.

Deuterium Capital Management first reported a position in CLMT in Q1 2024 and held it in 2 quarters. The position peaked at $172K in Q2 2024. 91 funds tracked by Wall St. Rank hold CLMT as of Q3 2024.

  • Deuterium Capital Management reported no remaining Calumet Specialty Products position as of Q3 2024 after selling out during the quarter.
  • Deuterium Capital Management sold 10,703 Calumet Specialty Products shares in Q3 2024, an estimated $172K.
  • Deuterium Capital Management first reported a position in Calumet Specialty Products in Q1 2024 and held it in 2 quarters.
  • Deuterium Capital Management's Calumet Specialty Products position peaked at $172K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2024.

Based on Deuterium Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.